Mehdi Zoghi Selected Research

Therapeutics

1/2024	Antiplatelet Treatment Preferences of a Group of Cardiologists from Türkiye: A Survey Research Study.
4/2021	Demographic, Clinical, and Angiographic Characteristics of Atrial Fibrillation Patients Suffering From de novo Acute Myocardial Infarction: A Subgroup Analysis of the MINOCA-TR Study Population.
1/2019	The Prevalence and Risks of Inappropriate Combination of Aspirin and Warfarin in Clinical Practice: Results From WARFARIN-TR Study
1/2019	The real-life data of hospitalized patients with heart failure: On behalf of the Journey HF-TR study investigators.
1/2018	The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study.
9/2016	Frequency of genetic polymorphism for adrenergic receptor beta and cytochrome p450 2D6 enzyme, and effects on tolerability of beta-blocker therapy in heart failure with reduced ejection fraction patients: The Beta GenTURK study.
12/2009	[Practical approach to acute heart failure with algorithms].
8/2008	[The determination of the factors impacting on in-hospital mortality in patients with acute heart failure in a tertiary referral center].
3/2007	[Pre-hospital thrombolytic therapy].
12/2004	The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mehdi Zoghi Research Topics

Disease

15	Heart Failure 12/2022 - 12/2005
6	Hypertension (High Blood Pressure) 05/2024 - 07/2003
5	ST Elevation Myocardial Infarction 01/2024 - 03/2007
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2024 - 09/2004
5	Atrial Fibrillation 01/2019 - 11/2011
4	Hemorrhage 01/2024 - 08/2017
3	Infarction (Infarctions) 01/2019 - 03/2007
3	Thrombosis (Thrombus) 09/2016 - 01/2002
2	Cardiac Arrhythmias (Arrythmia) 04/2021 - 11/2011
2	Coronary Disease (Coronary Heart Disease) 01/2019 - 08/2012
2	Pathologic Constriction (Stenosis) 02/2018 - 02/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 12/2005
2	Acute Coronary Syndrome 01/2013 - 12/2005
2	Insulin Resistance 11/2012 - 01/2006
2	Ischemia 04/2009 - 06/2007
2	Myocardial Bridging 02/2008 - 06/2007
1	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2024
1	COVID-19 03/2023
1	Abscess 04/2022
1	Embolism (Embolus) 04/2022
1	Diabetes Mellitus 09/2020
1	Vitamin D Deficiency 11/2019
1	Cardiomyopathies (Cardiomyopathy) 08/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Dementia (Dementias) 04/2018
1	Systolic Heart Failure 09/2016
1	Fistula 07/2015
1	Brugada Syndrome 03/2013
1	Unstable Angina 01/2013
1	Arteritis 01/2013
1	Vascular Diseases (Vascular Disease) 11/2012
1	Inflammation (Inflammations) 11/2012
1	Overweight 11/2012
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2012
1	Neoplasms (Cancer) 06/2011
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 03/2011
1	Infections 03/2011
1	Osteoporosis 05/2010
1	Myocardial Ischemia (Ischemic Heart Diseases) 04/2009
1	Hypocalcemia 01/2009
1	Vasovagal Syncope 12/2008
1	Metabolic Bone Diseases (Osteopenia) 03/2008
1	Atherosclerosis 02/2008
1	Hematologic Neoplasms (Hematological Malignancy) 06/2006
1	Hyperlipidemias (Hyperlipidemia) 01/2006

Drug/Important Bio-Agent (IBA)

4	DiureticsIBA 07/2015 - 12/2004
3	Antihypertensive Agents (Antihypertensives)IBA 05/2024 - 12/2004
3	Warfarin (Coumadin)FDA LinkGeneric 01/2019 - 08/2016
3	C-Reactive ProteinIBA 01/2013 - 09/2004
3	Simendan (Levosimendan)IBA 04/2009 - 01/2008
3	Dobutamine FDA LinkGeneric 04/2009 - 06/2007
3	CalciumIBA 01/2009 - 07/2003
2	CreatinineIBA 01/2024 - 07/2015
2	Vitamin D FDA LinkGeneric 11/2019 - 01/2009
2	Vitamin K FDA Link 05/2018 - 04/2018
2	AnticoagulantsIBA 05/2018 - 04/2018
2	N(4)-oleylcytosine arabinosideIBA 05/2018 - 04/2018
2	EnzymesIBA 09/2016 - 01/2013
2	ResistinIBA 08/2012 - 11/2011
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2024
1	TicagrelorIBA 01/2024
1	VaccinesIBA 03/2023
1	Nebivolol FDA Link 12/2022
1	AlbuminsIBA 04/2022
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021
1	Neprilysin (Neutral Endopeptidase)IBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2020
1	pro-brain natriuretic peptide (1-76)IBA 08/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	Cardiovascular AgentsIBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 09/2016
1	SolutionsIBA 09/2016
1	Heparin (Liquaemin)FDA LinkGeneric 09/2016
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 09/2016
1	beta Adrenergic ReceptorsIBA 09/2016
1	Propafenone (Rythmol)FDA LinkGeneric 03/2013
1	MB Form Creatine KinaseIBA 01/2013
1	Troponin T (Troponin T1)IBA 01/2013
1	chitotriosidaseIBA 01/2013
1	LipidsIBA 11/2012
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 11/2012
1	HomocysteineIBA 11/2012
1	Angiotensin Receptor AntagonistsIBA 06/2011
1	Vasodilator Agents (Vasodilators)IBA 12/2009
1	Biological FactorsIBA 12/2008
1	Indicators and Reagents (Reagents)IBA 02/2008
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 03/2007
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2006
1	Atorvastatin (Lipitor)FDA Link 01/2006

Therapy/Procedure

11	Therapeutics 01/2024 - 07/2003
6	Heart Transplantation (Grafting, Heart) 07/2015 - 01/2008
3	Thrombolytic Therapy 01/2019 - 01/2003
1	Percutaneous Coronary Intervention 01/2019
1	Secondary Prevention 01/2019
1	Heart-Assist Devices 09/2016
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2011
1	Aftercare (After-Treatment) 01/2009
1	Transplantation 06/2006
1	Drug Therapy (Chemotherapy) 06/2006